ACRON: 1st Quarter Results  30 May 2017 Acron's Q1

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
120
ACRON: 1st Quarter Results

  30 May 2017

Acron's Q1 2017 IFRS Revenue up 22% to USD 409 Million

Today Acron (Moscow Exchange and LSE: AKRN) released its consolidated IFRS financial statements for the first quarter of 2017.

Key Financials

  • Revenue was RUB 24,073 million, down 4% year-on-year (Q1 2016: RUB 25,015 million). In dollar equivalent, revenue was up 22% to USD 409 million from USD 335 million. 
  • EBITDA* was down 28% year-on-year to RUB 7,434 million (USD 126 million) (Q1 2016: RUB 10,286 million; USD 138 million)
  • EBITDA margin was 31%, against 41% for Q1 2016
  • Net profit was down 88% year-on-year to RUB 1,571 million (USD 27 million) (Q1 2016: RUB 12,657 million; USD 170 million)
  • Net debt was down 1% to RUB 51,369 million (31 December 2016: RUB 51,949 million). In dollar equivalent, net debt was up 6% to USD 911 million from USD 856 million.
  • Net debt / LTM EBITDA** was 1.9, against 1.7 as of 31 December 2016.

Operating Results

  • Output of key products was 1.773 million tonnes, up 18% year-on-year.
  • Sales of key products totalled 1.781 million tonnes, up 19% year-on-year.

Chairman of Acron's Board of Directors Alexander Popov comments on the results:

"First of all, I would like to emphasise the excellent operating results. Sales showed double-digit growth, which gives us an advantage against ever increasing competition on the global mineral fertiliser market. As a result, revenue in the reporting period was up 22% year-on-year in dollar equivalent.

At the same time, a stronger rouble and higher costs contributed to a decrease in EBITDA. EBITDA margin was 31%, which is close to the average over the past five years.

With the investment cycle over, we are reducing capital expenditures, which helps maintain the debt burden at a comfortable level.

In the reporting period, net profit was affected by a loss due to changes in the value of derivative financial instruments, specifically by the expiration of a call option for VPC shares. However, since this loss is non-monetary, it will not affect dividend amount".

APPENDIX

Notes on Key Items in the Financial Statements

Financial Performance

The Group's revenue in the first quarter of 2017 was RUB 24,073 million, down 4% year-on-year. In the reporting period, the global fertiliser market saw different trends for dollar prices: nitrogen fertiliser prices were up, and complex fertiliser prices were down year-on-year. Sales of key products increased 19% year-on-year. At the same time, in the first quarter of 2017, the average RUB to US dollar exchange rate was 21% lower year-on-year.

On the back of a 19% increase in sales, the cost of goods sold in the reporting period was up 21% to RUB 12,807 million. Cost growth was limited due to lower potassium chloride prices.

Selling, general and administrative expenses were down 2% to RUB 1,922 million due to lower foreign currency-denominated staff costs, including at the Group's foreign facilities. Transportation expenses were up 8% to RUB 3,510 million due to increased sales and indexation of Russia's railway tariff.

In the first quarter of 2017, EBITDA was RUB 7,434 million, down 28% year-on-year. EBITDA margin was 31%, down from 41% for the first quarter of 2016. The Group's Veliky Novgorod-based Acron and Dorogobuzh facilities operated at 28% and 26% margin, respectively. NWPC's EBITDA margin was down to 33% due to lower apatite concentrate prices. Based on the results of the first quarter of 2017, the Group posted a net exchange gain of RUB 1,901 million from revaluation of assets, loans and liabilities, against a gain of RUB 1,876 million for the first quarter of 2016.

In the reporting period, the Company posted a loss of RUB 5,079 million from a change in the fair value of derivatives. This paper loss is due to expiration of a call option on a stake of Sberbank Investments in the Talitsky potash project.

Net profit for the first quarter of 2017 was RUB 1,571 million, against RUB 12,657 million for the first three months of 2016. It is worth mentioning that net profit for the first quarter of 2016 was supported by a gain on disposal of investments of RUB 5,461 million, which was mainly due to sale of the Company's stake in Uralkali.

Cash Flow

In the first quarter of 2017, net operating cash flow was down 69% to RUB 1,169 million (first quarter of 2016: RUB 3,816 million) due to increased working capital and reduced operating profit.

Net cash used in investing activities in the reporting period was RUB 2,270 million, against RUB 1,662 million generated in the first quarter of 2016. CAPEX decreased 39% year-on-year to RUB 2,462 million, from RUB 4,040 million due to the completion of the active phase of the investment cycle.

Net cash used in financing activities in the first quarter of 2017 was RUB 10,635 million, against RUB 4,160 million generated in the first three months of 2016. The cash outflow was due to an excess of repayments over obtained borrowings.

Debt burden

In the first quarter of 2017, net debt was down 1% to RUB 51,369 million. The relative debt burden increased, and net debt / LTM EBITDA was 1.9, against 1.7 at the beginning of the year. This increase was due to lower EBITDA.

Market Trends

At the beginning of 2017, nitrogen fertiliser prices increased in response to strong demand prior to the spring sowing season in the northern hemisphere. In February 2017, prices for urea reached USD 260 FOB Baltic Sea. However, as spring sowing orders began to wind down, prices came under pressure. Market stabilisation was due to marginal Chinese producers. High production costs force them to maintain urea prices above USD 200 FOB China.

As prices for primary input products have improved, prices for NPK complex fertilisers have demonstrated growth since the beginning of the year, following a decline throughout 2016. NPK still retains its premium over the basic product basket.

Average Indicative Prices, USD/t, FOB Baltic Sea/Black Sea

  Q1 2017 Q4 2016 Q1 2016 Q1 2017 / Q4 2016 change Q1 2017 / Q1 2016 change
NPK 16-16-16 262 254 326 +3.0% -19.7%
AN 202 179 186 +12.9% +8.7%
UAN 158 133 152 +18.4% +3.4%
Urea 237 204 194 +16.1% +22.1%
Ammonia 302 190 270 +58.8% +12.0%

The full version of Acron Group's financial statements is available at www.acron.ru/en .

Note: The exchange rate for currency conversion was RUB 56.3779 to USD 1 as of 31 March 2017 and RUB 60.6569 to USD 1 as of 31 December 2016. The average exchange rate for the first three months of 2017 was RUB 58.8366 to USD 1. The average exchange rate for the first three months of 2016 was RUB 74.6283 to USD 1.

* EBITDA is calculated as operating profit adjusted for depreciation and amortisation , foreign exchange gain or loss, and other non-cash and extraordinary items.

** LTM EBITDA is EBITDA calculated for the past 12 months .

Media contacts:

Tatiana Smirnova Public Relations Phone: +7 (495) 777-08-65 (ext. 5196)

Investor contacts: Ilya Popov Investor Relations Phone:  +7 (495) 745-77-45 (ext. 5252)

Background Information

Acron Group is a leading vertically integrated mineral fertiliser producer in Russia and globally, with chemical production facilities in Veliky Novgorod (Acron) and Smolensk (Dorogobuzh). The Group owns and operates a phosphate mine in Murmansk region (NWPC) and plans to implement a potash development project in Perm Krai (VPC). It has a wholly owned transport and logistics infrastructure and distribution networks in Russia and China.

In 2016, the Group sold 6.4 million tonnes of various products to 63 countries, with Russia, Brazil, Europe and the United States as key markets.

In 2016, the Group posted consolidated revenue under IFRS of RUB 89,359 million (USD 1,333 million) and net profit of RUB 25,525 million (USD 381 million). Acron's shares are on the Level 1 quotation list of the Moscow Exchange and its global depositary receipts are traded at the London Stock Exchange (ticker AKRN). Acron employs over 11,000 people.

For more information about Acron Group, please visit www.acron.ru/en .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bernard Lancaster Steps Up as Mammoth's New President

Updated Category News Views 143

A New Era Under Bernard Lancaster at Mammoth Change is in the air for Mammoth Energy Services, as Bernard “Bernie” Lancaster takes the helm as President. His promotion on November 9, 2026, might not send shockwaves through Wall Street right away, but anyone holding an interest in NASDAQ:TUSK should take note. Lancaster's appointment is the kind of decision that...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 62

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Stent or Meds? Long-Term Study Questions Benefits

Updated Category News Views 101

The Long Game in Cardiology There's this long-standing debate in cardiology about whether sticking a metal stent in an artery actually prevents heart attacks or just looks impressive. Well, after chewing on 25 years of data from the COURAGE trial, CU Anschutz researchers led by Dr. Neel Butala have thrown a curveball — these stents might not be as life-saving as many...

Continue Reading
Finding the Right Auto Insurance: What to Consider

Updated Category News Views 107

Understanding the Basics of Auto Insurance Coverage Now, you might think the state knows best when it sets those minimum auto insurance requirements. But let's not kid ourselves—skimping on coverage can leave you high and dry if things go south on the road. That's where an expert voice like Corey Frazer's comes in, laying out why those limits often fall short. Minimum...

Continue Reading
Diwali Celebration in Chicago Honors Indian Community

Updated Category News Views 142

Chicago's Diwali Tribute: Music, Dance, and Diversity Talk about spreading the glow! On November 13, 2026, Cook County Treasurer Maria Pappas is gearing up to throw a Diwali bash that'll light up Chicago's cultural landscape. Alongside Indian Consul General Dr. M. Anand Prakash, she's orchestrating a vibrant affair designed to spotlight Indian American community leaders...

Continue Reading
Sports Clock Radio: A Game Time Enthusiast's Dream

Updated Category News Views 45

A New Gadget for the Diehard Fan Fanatics, gather 'round. There's an innovation rolling out that's looking to marry the good old alarm clock radio with the rush of game day fever! Over in Pittsburgh, an inventor's cooking up something that every loyal sports fan might soon find irresistible—a Sports Clock Radio, bringing the stadium experience to your living room or...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 40

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
GTEC Faces Nasdaq Bid Price Compliance Challenge

Updated Category News Views 51

Greenland Technologies in a Tight Spot Man, stocks can be as unpredictable as a cat on a hot tin roof, and Greenland Technologies Holding Corporation (Nasdaq: GTEC) just got a cold splash of reality from Nasdaq. On November 10, 2026, they were handed a Notification Letter that ain’t exactly a love note. Their shares slipped below the one-buck hurdle, and Nasdaq isn’t...

Continue Reading
vVARDIS Readies for Big Day on NYSE—IPO Set to Shine

Updated Category News Views 157

vVARDIS Stepping into the Spotlight of the NYSE Alright, folks, here's one that could make some waves. vVARDIS is gearing up for its NYSE debut, trading under the ticker VVVV. They're no small fry talking about 9.72 million shares priced at 18 bucks a pop. This isn't just any run-of-the-mill company; they claim to have the first peptide-containing formulation for early...

Continue Reading
Cuisine.K Brings Korean Seafood to Seattle Spotlight

Updated Category News Views 93

Korean Seafood Makes Waves in Seattle Bring out the chopsticks, ‘cause Korean seafood just took Seattle by storm with the Cuisine.K Korean culinary showcase. Hosted by CJ Foods, alongside the Korea Fisheries Association, this event smacked the local food scene square in the face with the unique flavors and techniques of K-Seafood—from students all the way to seasoned...

Continue Reading

Top 5 Most Recently Viewed Articles

Avita Medical's Recell Go Mini FDA Approval Boosts Stock

Updated Category News Views 190

Avita Medical’s Recell Go Mini Secures FDA Approval Avita Medical (NASDAQ: RCEL) has recently achieved a significant milestone as its Recell Go mini received approval from the US Food and Drug Administration (FDA). This news sparked a remarkable surge of over 6% in the stock during post-market trading. This approval represents a key advancement for Avita Medical and its...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 444

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Driving Engagement in Diabetes Management Through TV Ads

Updated Category News Views 326

Unlocking Consumer Engagement in Diabetes Advertising As the landscape of diabetes management continues to evolve, the synergy between innovative treatments and effective advertising strategies is crucial. Recent analysis highlights how companies like Dexcom, Ozempic, and Mounjaro are capturing consumer attention through targeted covrergent TV advertising methods. Key...

Continue Reading
Analyzing D.R. Horton's Increasing Short Interest Dynamics

Updated Category News Views 99

Understanding D.R. Horton's Short Interest Trends D.R. Horton's DHI short interest has recently noted a significant increase, currently standing at 7.22 million shares sold short. This accounts for 2.89% of the company’s available trading shares. Traders should take note that it would take approximately 1.95 days, based on current trading volume, to cover these short...

Continue Reading
Tint World® Celebrates Franchise Success and Recognition

Updated Category News Views 172

Celebrating Franchise Success at the Tint World® Convention Tint World® Automotive Styling Centers™, a prominent leader in auto accessories and window tinting franchises, recently gathered franchise owners from around the globe to celebrate achievements and recognize the burgeoning members of its prestigious Million Dollar Club at their annual International Franchise...

Continue Reading